financetom
Business
financetom
/
Business
/
Exxon hit with $725.5 million verdict over mechanic's leukemia diagnosis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exxon hit with $725.5 million verdict over mechanic's leukemia diagnosis
May 10, 2024 8:53 AM

May 10 (Reuters) - A Pennsylvania jury ordered

ExxonMobil ( XOM ) to pay $725.5 million to a former mechanic who

claimed toxic chemicals in the company's gasoline and solvents

caused his cancer, according to attorneys for the plaintiff.

The 10-2 verdict came on Thursday, attorneys said, after a

trial in a state court in Philadelphia, where former mechanic

Paul Gill alleged he was exposed to benzene in ExxonMobil ( XOM )

products while working at a gas station between 1975 and 1980.

Following the trial that lasted just over a week, the jury

found Exxon liable for negligently failing to warn about the

health risks of benzene, which the U.S. Environmental Protect

Agency (EPA) has classified as a known carcinogen. The entire

verdict was in compensatory damages, according to Gill's

attorneys.

An Exxon spokesperson called the verdict "irrational" and

said the company would ask the court to reverse it, and that it

planned to "exhaust all available appeals."

The 67-year-old former mechanic said in his 2020 lawsuit

that he used petroleum products to clean car parts with his bare

hands, which exposed him to benzene through direct skin contact

and inhalation.

He was diagnosed with acute myeloid leukemia, a type of

blood cancer, in 2019.

"This verdict is important because it's a finding that their

gasoline causes cancer," said Patrick Wigle, an attorney for

Gill, in a statement. "ExxonMobil ( XOM ) has known for decades that

benzene causes cancer, yet they resisted warning the public and

taking basic precautions to warn the public and limit exposure."

Benzene is widely used in the United States in motor fuels,

as a solvent for resins and plastics, and for other industrial

purposes.

The EPA, which limits the amount of benzene that is

acceptable in fuels, says it also can be found in emissions from

burning coal and oil, from car exhaust and from evaporation at

gas stations, among other things.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Citi poaches back banker who had quit to join JPM, sources say
Citi poaches back banker who had quit to join JPM, sources say
Apr 12, 2024
By Shankar Ramakrishnan April 12 (Reuters) - Citigroup ( C/PN ) has rehired an investment banker who had quit to work for JPMorgan Chase ( JPM ) even before he started work there, two sources with knowledge of the matter said on Friday. Arvind Vashistha was on gardening leave after leaving his job at Citi in early February to join...
Netflix Likely to See Higher Q1 Revenue as Paid Sharing Benefits Continue, Oppenheimer Says
Netflix Likely to See Higher Q1 Revenue as Paid Sharing Benefits Continue, Oppenheimer Says
Apr 12, 2024
12:05 PM EDT, 04/12/2024 (MT Newswires) -- Netflix ( NFLX ) is likely to report higher Q1 revenue April 18 as long-tail benefits of paid sharing become increasingly evident, Oppenheimer said in a note Thursday. Analysts, including Jason Helfstein, said that Netflix ( NFLX ) has captured about 20% of the 100 million disclosed opportunity for paid sharing, and could...
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies
Apr 12, 2024
Friday, PaxMedica Inc ( PXMD ) completed the execution of its three pivotal registration/validation batches of PAX-101, an IV formulation of suramin.  This achievement is an essential milestone in enabling a New Drug Application submission to the FDA, which is currently planned for Q4 2024, and the potential commercial availability in the U.S. of the first and only form of suramin for Stage...
JPMorgan's Net Interest Income Outlook Is 'Moderate Disappointment' Amid 'Solid' Q1 Results, HSBC Says
JPMorgan's Net Interest Income Outlook Is 'Moderate Disappointment' Amid 'Solid' Q1 Results, HSBC Says
Apr 12, 2024
12:02 PM EDT, 04/12/2024 (MT Newswires) -- JPMorgan Chase's ( JPM ) net interest income outlook this year probably was assessed as a moderate disappointment amid solid Q1 results on a decrease in loan losses, higher non-interest income and lower expenses, HSBC Global Research said Friday in a note. JPMorgan ( JPM ) kept its 2024 net interest income outlook...
Copyright 2023-2026 - www.financetom.com All Rights Reserved